Epstein-barr virus (EBV) rta-mediated EBV and Kaposi's sarcoma-associated herpesvirus lytic reactivations in 293 cells

PLoS ONE

Volumn 6, Issue 3, 2011, Pages

  Chen, Yen Ju ^a,b   Tsai, Wan Hua ^b   Chen, Yu Lian ^b   Ko, Ying Chieh ^b   Chou, Sheng Ping ^b   Chen, Jen Yang ^a,b   Lin, Su Fang ^b  

^a NATIONAL TAIWAN UNIVERSITY   (Taiwan)

^b NATIONAL HEALTH RESEARCH INSTITUTES   (Taiwan)

Author keywords

[No Author keywords available]

Indexed keywords

BETA GALACTOSIDASE; DOXYCYCLINE; IMMEDIATE EARLY PROTEIN; VIRUS PROTEIN;

ARTICLE; CELL AGING; CELL CYCLE ARREST; CELL CYCLE PROGRESSION; CELL CYCLE REGULATION; CELL DEATH; CELL STRAIN HEK293; CONTROLLED STUDY; CYTOLYSIS; EPSTEIN BARR VIRUS; EPSTEIN BARR VIRUS RTA GENE; GAMMAHERPESVIRINAE; GENE EXPRESSION; GENETIC CONSERVATION; HOST CELL; HUMAN HERPESVIRUS 8; MULTIGENE FAMILY; VIRUS GENE; VIRUS GENOME; VIRUS LATENCY; VIRUS REACTIVATION; VIRUS RECOMBINANT; VIRUS REPLICATION; CELL CYCLE G1 PHASE; CELL LINE; CELL PROLIFERATION; DRUG EFFECT; GENE EXPRESSION REGULATION; GENETICS; HUMAN; METABOLISM; NASOPHARYNX CARCINOMA; NASOPHARYNX TUMOR; PATHOLOGY; PHYSIOLOGY; TIME; TUMOR CELL LINE; VIRUS ACTIVATION;

HUMAN HERPESVIRUS 4; HUMAN HERPESVIRUS 8;

CELL DEATH; CELL LINE; CELL LINE, TUMOR; CELL PROLIFERATION; DOXYCYCLINE; G1 PHASE; GENE EXPRESSION REGULATION, VIRAL; HERPESVIRUS 4, HUMAN; HERPESVIRUS 8, HUMAN; HUMANS; IMMEDIATE-EARLY PROTEINS; NASOPHARYNGEAL NEOPLASMS; TIME FACTORS; VIRAL PROTEINS; VIRUS ACTIVATION; VIRUS REPLICATION;

EID: 79952521991     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0017809     Document Type: Article

References (60)

1. Pauk J, Huang ML, Brodie SJ, Wald A, Koelle DM, et al. (2000) Mucosal shedding of human herpesvirus 8 in men. N Engl J Med 343: 1369-1377.
2. Sixbey JW, Nedrud JG, Raab-Traub N, Hanes RA, Pagano JS, (1984) Epstein-Barr virus replication in oropharyngeal epithelial cells. N Engl J Med 310: 1225-1230.
3. Thorley-Lawson DA, (2005) EBV the prototypical human tumor virus-just how bad is it? J Allergy Clin Immunol 116: 251-261; quiz 262.
4. Feederle R, Neuhierl B, Bannert H, Geletneky K, Shannon-Lowe C, et al. (2007) Epstein-Barr virus B95.8 produced in 293 cells shows marked tropism for differentiated primary epithelial cells and reveals interindividual variation in susceptibility to viral infection. Int J Cancer 121: 588-594.
5. Johnson AS, Maronian N, Vieira J, (2005) Activation of Kaposi's sarcoma-associated herpesvirus lytic gene expression during epithelial differentiation. J Virol 79: 13769-13777.
6. Young LS, Lau R, Rowe M, Niedobitek G, Packham G, et al. (1991) Differentiation-associated expression of the Epstein-Barr virus BZLF1 transactivator protein in oral hairy leukoplakia. J Virol 65: 2868-2874.
7. Sun CC, Thorley-Lawson DA, (2007) Plasma cell-specific transcription factor XBP-1s binds to and transactivates the Epstein-Barr virus BZLF1 promoter. J Virol 81: 13566-13577.
8. Wilson SJ, Tsao EH, Webb BL, Ye H, Dalton-Griffin L, et al. (2007) X box binding protein XBP-1s transactivates the Kaposi's sarcoma-associated herpesvirus (KSHV) ORF50 promoter, linking plasma cell differentiation to KSHV reactivation from latency. J Virol 81: 13578-13586.
9. Blomen VA, Boonstra J, (2007) Cell fate determination during G1 phase progression. Cell Mol Life Sci 64: 3084-3104.
10. Pfeuty B, David-Pfeuty T, Kaneko K, (2008) Underlying principles of cell fate determination during G1 phase of the mammalian cell cycle. Cell Cycle 7: 3246-3257.
11. Sekeri-Pataryas KE, Sourlingas TG, (2007) The differentiation-associated linker histone, H1.0, during the in vitro aging and senescence of human diploid fibroblasts. Ann N Y Acad Sci 1100: 361-367.
12. Hwang ES, (2002) Replicative senescence and senescence-like state induced in cancer-derived cells. Mech Ageing Dev 123: 1681-1694.
13. Serrano M, Lin AW, McCurrach ME, Beach D, Lowe SW, (1997) Oncogenic ras provokes premature cell senescence associated with accumulation of p53 and p16INK4a. Cell 88: 593-602.
14. Collado M, Serrano M, (2010) Senescence in tumours: evidence from mice and humans. Nat Rev Cancer 10: 51-57.
15. Mooi WJ, Peeper DS, (2006) Oncogene-induced cell senescence-halting on the road to cancer. N Engl J Med 355: 1037-1046.
16. Wu CH, van Riggelen J, Yetil A, Fan AC, Bachireddy P, et al. (2007) Cellular senescence is an important mechanism of tumor regression upon c-Myc inactivation. Proc Natl Acad Sci U S A 104: 13028-13033.
17. Soucek L, Whitfield J, Martins CP, Finch AJ, Murphy DJ, et al. (2008) Modelling Myc inhibition as a cancer therapy. Nature 455: 679-683.
18. Flemington EK, (2001) Herpesvirus lytic replication and the cell cycle: arresting new developments. J Virol 75: 4475-4481.
19. Inman GJ, Binne UK, Parker GA, Farrell PJ, Allday MJ, (2001) Activators of the Epstein-Barr virus lytic program concomitantly induce apoptosis, but lytic gene expression protects from cell death. J Virol 75: 2400-2410.
20. Kudoh A, Fujita M, Kiyono T, Kuzushima K, Sugaya Y, et al. (2003) Reactivation of lytic replication from B cells latently infected with Epstein-Barr virus occurs with high S-phase cyclin-dependent kinase activity while inhibiting cellular DNA replication. J Virol 77: 851-861.
21. Hobbs WE 2nd, DeLuca NA, (1999) Perturbation of cell cycle progression and cellular gene expression as a function of herpes simplex virus ICP0. J Virol 73: 8245-8255.
22. Noris E, Zannetti C, Demurtas A, Sinclair J, De Andrea M, et al. (2002) Cell cycle arrest by human cytomegalovirus 86-kDa IE2 protein resembles premature senescence. J Virol 76: 12135-12148.
23. Ragoczy T, Heston L, Miller G, (1998) The Epstein-Barr virus Rta protein activates lytic cycle genes and can disrupt latency in B lymphocytes. J Virol 72: 7978-7984.
24. Zalani S, Holley-Guthrie E, Kenney S, (1996) Epstein-Barr viral latency is disrupted by the immediate-early BRLF1 protein through a cell-specific mechanism. Proc Natl Acad Sci U S A 93: 9194-9199.
25. Sun R, Lin SF, Gradoville L, Yuan Y, Zhu F, et al. (1998) A viral gene that activates lytic cycle expression of Kaposi's sarcoma- associated herpesvirus. Proc Natl Acad Sci U S A 95: 10866-10871.
26. Lukac DM, Kirshner JR, Ganem D, (1999) Transcriptional activation by the product of open reading frame 50 of Kaposi's sarcoma-associated herpesvirus is required for lytic viral reactivation in B cells. J Virol 73: 9348-9361.
27. Chen YL, Chen YJ, Tsai WH, Ko YC, Chen JY, et al. (2009) The Epstein-Barr virus replication and transcription activator, Rta/BRLF1, induces cellular senescence in epithelial cells. Cell Cycle 8: 58-65.
28. Lee CP, Huang YH, Lin SF, Chang Y, Chang YH, et al. (2008) Epstein-Barr virus BGLF4 kinase induces disassembly of the nuclear lamina to facilitate virion production. J Virol 82: 11913-11926.
29. Vieira J, O'Hearn PM, (2004) Use of the red fluorescent protein as a marker of Kaposi's sarcoma-associated herpesvirus lytic gene expression. Virology 325: 225-240.
30. Blagosklonny MV, (2006) Cell senescence: hypertrophic arrest beyond the restriction point. J Cell Physiol 209: 592-597.
31. Demidenko ZN, Blagosklonny MV, (2008) Growth stimulation leads to cellular senescence when the cell cycle is blocked. Cell Cycle 7: 3355-3361.
32. Li Y, Mahajan NP, Webster-Cyriaque J, Bhende P, Hong GK, et al. (2004) The C-mer gene is induced by Epstein-Barr virus immediate-early protein BRLF1. J Virol 78: 11778-11785.
33. Li Y, Webster-Cyriaque J, Tomlinson CC, Yohe M, Kenney S, (2004) Fatty acid synthase expression is induced by the Epstein-Barr virus immediate-early protein BRLF1 and is required for lytic viral gene expression. J Virol 78: 4197-4206.
34. Huang da W, Sherman BT, Lempicki RA, (2009) Systematic and integrative analysis of large gene lists using DAVID bioinformatics resources. Nat Protoc 4: 44-57.
35. Zhang B, Kirov S, Snoddy J, (2005) WebGestalt: an integrated system for exploring gene sets in various biological contexts. Nucleic Acids Res 33: W741-748.
36. Campisi J, d'Adda di Fagagna F, (2007) Cellular senescence: when bad things happen to good cells. Nat Rev Mol Cell Biol 8: 729-740.
37. Li X, Chen S, Feng J, Deng H, Sun R, (2010) Myc is required for the maintenance of Kaposi's sarcoma-associated herpesvirus latency. J Virol.
38. Chen LW, Chang PJ, Delecluse HJ, Miller G, (2005) Marked variation in response of consensus binding elements for the Rta protein of Epstein-Barr virus. J Virol 79: 9635-9650.
39. Gruffat H, Sergeant A, (1994) Characterization of the DNA-binding site repertoire for the Epstein-Barr virus transcription factor R. Nucleic Acids Res 22: 1172-1178.
40. Schultz J, Ibrahim SM, Vera J, Kunz M, (2009) 14-3-3sigma gene silencing during melanoma progression and its role in cell cycle control and cellular senescence. Mol Cancer 8: 53.
41. Cayrol C, Flemington EK, (1996) The Epstein-Barr virus bZIP transcription factor Zta causes G0/G1 cell cycle arrest through induction of cyclin-dependent kinase inhibitors. Embo J 15: 2748-2759.
42. Izumiya Y, Lin SF, Ellison TJ, Levy AM, Mayeur GL, et al. (2003) Cell cycle regulation by Kaposi's sarcoma-associated herpesvirus K-bZIP: direct interaction with cyclin-CDK2 and induction of G1 growth arrest. J Virol 77: 9652-9661.
43. Rodriguez A, Jung EJ, Flemington EK, (2001) Cell cycle analysis of Epstein-Barr virus-infected cells following treatment with lytic cycle-inducing agents. J Virol 75: 4482-4489.
44. Wu FY, Chen H, Wang SE, ApRhys CM, Liao G, et al. (2003) CCAAT/enhancer binding protein alpha interacts with ZTA and mediates ZTA-induced p21(CIP-1) accumulation and G(1) cell cycle arrest during the Epstein-Barr virus lytic cycle. J Virol 77: 1481-1500.
45. Wu FY, Tang QQ, Chen H, ApRhys C, Farrell C, et al. (2002) Lytic replication-associated protein (RAP) encoded by Kaposi sarcoma-associated herpesvirus causes p21CIP-1-mediated G1 cell cycle arrest through CCAAT/enhancer-binding protein-alpha. Proc Natl Acad Sci U S A 99: 10683-10688.
46. Guo Q, Qian L, Guo L, Shi M, Chen C, et al. (2010) Transactivators Zta and Rta of Epstein-Barr virus promote G0/G1 to S transition in Raji cells: a novel relationship between lytic virus and cell cycle. Mol Immunol 47: 1783-1792.
47. Swenson JJ, Mauser AE, Kaufmann WK, Kenney SC, (1999) The Epstein-Barr virus protein BRLF1 activates S phase entry through E2F1 induction. J Virol 73: 6540-6550.
48. Zacny VL, Wilson J, Pagano JS, (1998) The Epstein-Barr virus immediate-early gene product, BRLF1, interacts with the retinoblastoma protein during the viral lytic cycle. J Virol 72: 8043-8051.
49. Greenspan JS, Greenspan D, Lennette ET, Abrams DI, Conant MA, et al. (1985) Replication of Epstein-Barr virus within the epithelial cells of oral "hairy" leukoplakia, an AIDS-associated lesion. N Engl J Med 313: 1564-1571.
50. Hadinoto V, Shapiro M, Sun CC, Thorley-Lawson DA, (2009) The dynamics of EBV shedding implicate a central role for epithelial cells in amplifying viral output. PLoS Pathog 5: e1000496.
51. Wells SI, Francis DA, Karpova AY, Dowhanick JJ, Benson JD, et al. (2000) Papillomavirus E2 induces senescence in HPV-positive cells via pRB- and p21(CIP)-dependent pathways. Embo J 19: 5762-5771.
52. Psyrri A, DeFilippis RA, Edwards AP, Yates KE, Manuelidis L, et al. (2004) Role of the retinoblastoma pathway in senescence triggered by repression of the human papillomavirus E7 protein in cervical carcinoma cells. Cancer Res 64: 3079-3086.
53. Wells SI, Aronow BJ, Wise TM, Williams SS, Couget JA, et al. (2003) Transcriptome signature of irreversible senescence in human papillomavirus-positive cervical cancer cells. Proc Natl Acad Sci U S A 100: 7093-7098.
54. Kalla M, Schmeinck A, Bergbauer M, Pich D, Hammerschmidt W, (2009) AP-1 homolog BZLF1 of Epstein-Barr virus has two essential functions dependent on the epigenetic state of the viral genome. Proc Natl Acad Sci U S A 107: 850-855.
55. Zhuang D, Mannava S, Grachtchouk V, Tang WH, Patil S, et al. (2008) C-MYC overexpression is required for continuous suppression of oncogene-induced senescence in melanoma cells. Oncogene 27: 6623-6634.
56. Liu J, Martin HJ, Liao G, Hayward SD, (2007) The Kaposi's sarcoma-associated herpesvirus LANA protein stabilizes and activates c-Myc. J Virol 81: 10451-10459.
57. Wells R, Stensland L, Vieira J, (2009) The human cytomegalovirus UL112-113 locus can activate the full Kaposi's sarcoma-associated herpesvirus lytic replication cycle. J Virol 83: 4695-4699.
58. Harrington W Jr, Sieczkowski L, Sosa C, Chan-a-Sue S, Cai JP, et al. (1997) Activation of HHV-8 by HIV-1 tat. Lancet 349: 774-775.
59. Lin CT, Chan WY, Chen W, Huang HM, Wu HC, et al. (1993) Characterization of seven newly established nasopharyngeal carcinoma cell lines. Lab Invest 68: 716-727.
60. Turk SM, Jiang R, Chesnokova LS, Hutt-Fletcher LM, (2006) Antibodies to gp350/220 enhance the ability of Epstein-Barr virus to infect epithelial cells. J Virol 80: 9628-9633.